NCA30952 Perkin Elmer Opera, SE Funded, SCRM

CPV: Microscopes

Procedure method

Award procedure without prior publication of a call for competition

Legal basis

CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)

Procurement category

Goods

Notice status

Awarded without competition

Procurement threshold

Unspecified in notice

Regulatory regime

Standard

Commercial structure

Stand-alone contract (no framework)

Competition type

Direct award (no call for competition)

GPA / WTO covered

Yes (GPA)

Recurring procurement

Unspecified in notice

First published

26 Mar 2021, 15:56 GMT

Last source update

26 Mar 2021, 15:56 GMT

Authority reference

NCA30952

FTS notice number

2021/S 000-006255

Classification (CPV)

Microscopes

Delivery area

Scotland (UKM75)

Official registry OCID

ocds-h6vhtk-029fe1 Find a Tender

Why no open competition

The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons

Published justification

This purchase will ensure continuity of our data processing and experimental setup, Columbus is not interchangeable with other high content platforms currently on the market. If we purchased an alternative platform, it would also require additional licenses for new software and computer hardware, these collateral costs are beyond our current budgetary scope. The Opera Phenix Plus is the only high content screening system available on the market that: i) Will be equipped with up to 3 proprietary high NA automated water immersion objectives of different magnifications for shorter measurement times and improved z-resolution in 3D imaging. This technology is covered by two patent families, granted EP1386189 B1, US7304793 B2:” and EP1646902 B1, US7961384 B2:. It will allow us to visualise in 3D spheroids, organoids and embryos in higher resolution and clarity. This is one of the highest priority in our research scopes to have instrument capable of 3D imaging for 3D disease models. Additionally, it will let us resolve the very small details in cells like protein interaction and RNA localisation and perform neuronal assays (spine analysis, vesicles). ii) Employs a micro lens enhanced dual Nipkow spinning disk concept with proprietary confocal Synchrony Optics™ which separates excitation of adjacent fluorescence channels in time and space to reduce spectral crosstalk during simultaneous multicolor confocal imaging on average by 98%. This technology is covered by patent, granted US Patent 9,612,428. This will allow us to use more colours to be imaged simultaneously with unprecedented speed rendering images without crosstalk between colours making analysis data much easier. This is vital to analyse small details like intracellular organelles. Synchrony Optics™ is crucial for high throughput assays such as compound screens because it removes the need for image post processing reducing time and a storage. iii) Patent-pending PreciScan extension which determines the z-position of the object and use it in a re-scan. PreciScan allows to quickly find region of interest in low magnification and rescan it in higher magnification for more details. This feature is of most importance for our imaging needs allowing us to perform detection of rare events happening in cells, reduction of data load and increase of imaging speed.

Publisher note: This purchase will ensure continuity of our data processing and experimental setup, Columbus is not interchangeable with other high content platforms currently on the market. If we purchased an alternative platform, it would also require additional licenses for new software and computer hardware, these collateral costs are beyond our current budgetary scope. The Opera Phenix Plus is the only high content screening system available on the market that: 1) Will be equipped with up to 3 proprietary high NA automated water immersion objectives of different magnifications for shorter measurement times and improved z-resolution in 3D imaging. This technology is covered by two patent families, granted EP1386189 B1, US7304793 B2:” and EP1646902 B1, US7961384 B2:. It will allow us to visualise in 3D spheroids, organoids and embryos in higher resolution and clarity. This is one of the highest priority in our research scopes to have instrument capable of 3D imaging for 3D disease models. Additionally, it will let us resolve the very small details in cells like protein interaction and RNA localisation and perform neuronal assays (spine analysis, vesicles). 2) Employs a micro lens enhanced dual Nipkow spinning disk concept with proprietary confocal Synchrony Optics™ which separates excitation of adjacent fluorescence channels in time and space to reduce spectral crosstalk during simultaneous multicolor confocal imaging on average by 98%. This technology is covered by patent, granted US Patent 9,612,428. This will allow us to use more colours to be imaged simultaneously with unprecedented speed rendering images without crosstalk between colours making analysis data much easier. This is vital to analyse small details like intracellular organelles. Synchrony Optics™ is crucial for high throughput assays such as compound screens because it removes the need for image post processing reducing time and a storage. 3) Patent-pending PreciScan extension which determines the z-position of the object and use it in a re-scan. PreciScan allows to quickly find region of interest in low magnification and rescan it in higher magnification for more details. This feature is of most importance for our imaging needs allowing us to perform detection of rare events happening in cells, reduction of data load and increase of imaging speed. (SC Ref:648972)

• Perkin Elmer LAS LtdAwarded supplier Chalfont Road, Seer Green / Buckinghamshire, South East, HP9 2FX

No document links were published on the notice.